{"text": ["XBIO", "To", "Report", "Phase", "2", "Data", "This", "Year,", "VNRX", "Abuzz,", "ATRS", "To", "Face", "FDA", "In", "Sep"], "created_at": "2018-08-13 21:36:00"}
{"text": ["XBIO", "To", "Report", "Phase", "2", "Data", "This", "Year,", "VNRX", "Abuzz,", "ATRS", "To", "Face", "FDA", "In", "Sep"], "created_at": "2018-08-13 21:36:00"}
{"text": ["Shire,", "Shionogi", "File", "NDA", "for", "Intuniv", "for", "Adults", "in", "Japan"], "created_at": "2018-08-13 18:24:27"}
{"text": ["Shire,", "Shionogi", "File", "NDA", "for", "Intuniv", "for", "Adults", "in", "Japan"], "created_at": "2018-08-13 18:24:27"}
{"text": ["Ionis", "Pharmaceuticals'", "Royalties", "Rise,", "but", "So", "Do", "Expenses"], "created_at": "2018-08-13 18:23:41"}
{"text": ["Ionis", "Pharmaceuticals'", "Royalties", "Rise,", "but", "So", "Do", "Expenses"], "created_at": "2018-08-13 18:23:41"}
{"text": ["How", "GlaxoSmithKline\u2019s", "Segments", "Have", "Performed"], "created_at": "2018-08-13 18:10:02"}
{"text": ["How", "GlaxoSmithKline\u2019s", "Valuation", "Compares", "with", "Peers\u2019"], "created_at": "2018-08-13 15:07:00"}
{"text": ["CAH", "Named", "Top", "25", "SAFE", "Dividend", "Stock", "Increasing", "Payments", "For", "Decades"], "created_at": "2018-08-13 14:07:49"}
{"text": ["CAH", "Named", "Top", "25", "SAFE", "Dividend", "Stock", "Increasing", "Payments", "For", "Decades"], "created_at": "2018-08-13 14:07:49"}
{"text": ["Eli", "Lilly", "and", "Company", "(LLY)", "Ex-Dividend", "Date", "Scheduled", "for", "August", "14,", "2018"], "created_at": "2018-08-13 13:22:34"}
{"text": ["Eli", "Lilly", "and", "Company", "(LLY)", "Ex-Dividend", "Date", "Scheduled", "for", "August", "14,", "2018"], "created_at": "2018-08-13 13:22:34"}
